Endospan Receives FDA Approval for the NEXUS® Aortic Arch Stent Graft System
· Financial Post
TEL AVIV, Israel -- Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the NEXUS® Aortic Arch Stent Graft. Read More
Visit turconews.click for more information.